ANANDA DEVELOPMENTS
PLC
("Ananda"
or the "Company")
Ananda Appoints Data and
Analytics Expert
Ananda Developments Plc ('Ananda'), a
company whose ambition is to be a leading provider of
cannabinoid-based medicines for the treatment of complex, chronic
inflammatory pain conditions, is pleased to announce the
appointment of Vitalii Ratushnyi as an adviser to the Company
with a focus on data and analytics.
Vitalii is a data, analytics, and
quantitative modelling expert. His appointment gives Ananda the
analytical capability to better target its research activities by
identifying potential current and new disease areas where
cannabinoids may be efficacious. His expertise in big data will
enable Ananda to assess patient populations in areas of unmet need
and support new cannabinoid drug development. Vitalii's focus will
be on creating a database of over 10,000 diseases which have
symptoms for which cannabinoids may have potential for activity.
The database will then be refined to conditions which have evidence
that cannabidiol has treatment potential. Refinement and
interrogation will provide Ananda with information sets to identify
clinical trial research opportunities. The Company's objective is
to provide the evidence required to get cannabis-based medicines
available on the NHS.
Ananda CEO Melissa Sturgess commented
"We believe our ability to get to
grips with large biological and genetic data sets will help us find
opportunities for our cannabinoid medicines, guide the design of
clinical trials and will be a cornerstone of our success. This work
is critical for the rapid development of our clinical trials
pipeline and intellectual property estate."
Biography
Vitalii holds a Master of Business
Administration from the Kyiv University of Technology and Design,
where he majored in Computer Science and minored in Behavioural
Psychology. Vitalii has nine years of experience in the technology
sector, beginning his career as a Data Engineer and Solution
Architect for several Israeli companies. He has also been a
foundational engineer in various start-ups, bringing his unique
perspective and technical skills to the forefront of innovation.
Vitalii currently works at an investment fund, where he creates
quantitative models and tools to support investment
decisions.
To stay up to date with the latest
developments at Ananda, we encourage you to follow and join our
social media channels which are:
·
Register at our Investor Hub:
https://investors.anandadevelopments.com/s/a66906
·
Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
·
LinkedIn:
https://www.linkedin.com/company/anadevelopments/
·
Twitter:
https://twitter.com/AnandaPlc
·
Investor Meet Company:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept
responsibility for the contents of this announcement.
For
more information please contact:
InvestorHub
Engage with us directly at Ananda
Developments Investor Hub
|
Sign up at https://investors.anandadevelopments.com/s/a66906
|
ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess
Executive
Director
Jeremy Sturgess-Smith
|
+44 (0)7463 686 497
ir@anandadevelopments.com
|
SP
ANGEL CORPORATE FINANCE LLP
Corporate Finance
Richard Morrison
Harry Davies-Ball
|
+44 (0)20 3470 0470
|
Corporate Broking
Abigail Wayne
Rob Rees
|
|
Yellow Jersey PR
Charles Goodwin
Soraya Jackson
|
+44 (0)20 3004 9512
|
About Ananda Developments
Ananda is an AQSE-listed company
whose ambition is to be a leading provider of
cannabinoid-based
medicines for the treatment of
complex, chronic inflammatory pain conditions.
For further information on the
Company visit https://anandadevelopments.com/
or sign up at https://investors.anandadevelopments.com/s/a66906.
https://investors.anandadevelopments.com/link/Ky0KoP